If History Repeats, Biotech Traders Will Have Fun Next Week. Here's Why.
Take a look at the chart included in a preview note published by J.P. Morgan's analysts. The data, itself, come from Bloomberg. J.P. Morgan:
I would have preferred to see the analysis conducted with the more inclusive Nasdaq Biotechnology Index (NBI) because the BTK tracks fewer stocks.
We assessed BTK performance relative to the S&P 500 during the week of the J.P. Morgan Healthcare Conference over the past 13 years. We observed that 85% of the time (all but 2 years), the BTK outperformed the S&P 500. From Monday to Friday during the week of the conference, the BTK increased on average by 3.0%, vs. flat S&P 500. Thus, the BTK outperformed the S&P 500 by ~2.9% on average during the week of the conference over the past 13 years
-- Reported by Adam Feuerstein in Boston. Follow Adam Feuerstein on Twitter.